Maiva Pharma Profile
Key Indicators
- Authorised Capital ₹ 31.03 Cr
- Paid Up Capital ₹ 24.66 Cr
- Company Age 31 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 268.00 Cr
- Satisfied Charges ₹ 4.10 Cr
- Revenue Growth 28.82%
- Profit Growth 44.38%
- Ebitda 43.55%
- Net Worth 36.72%
- Total Assets 62.78%
About Maiva Pharma
Maiva Pharma Private Limited (MPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 05 February 1993 and has a history of 31 years and 11 months. Its registered office is in Bangaluru, Karnataka, India.
The Corporate was formerly known as Global Parenterals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 31.03 Cr and a paid-up capital of Rs 24.66 Cr.
The company currently has active open charges totaling ₹268.00 Cr. The company has closed loans amounting to ₹4.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Maiva Pharma Private Limited India is Shivananda Hegde as COMPANY SECRETARY. Buggana Hariharnath, Arumugam Krishna, Nirav Mehta, and Two other members serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231KA1993PTC013976
- Company No.
013976
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Feb 1993
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
What products or services does Maiva Pharma Private Limited offer?
Maiva Pharma Private Limited offers a wide range of products and services, including Volumetric Filling Machine, Ampoule Filling Machine, Quality Inspection Service, Inspection Service, Water Treatment & Purification Plant, Water Purification Plants.
Who are the key members and board of directors at Maiva Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shivananda Hegde  | Company Secretary | 21-Jan-2011 | Current |
Arumugam Krishna  | Managing Director | 27-May-2013 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nirav Mehta | Director | 09-May-2024 | Current |
| Buggana Hariharnath | Additional Director | 26-Sep-2024 | Current |
| Janardhan | Whole-Time Director | 25-Aug-2021 | Current |
| Vaibhav Bagri | Nominee Director | 19-Aug-2024 | Current |
Financial Performance of Maiva Pharma.
Maiva Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.82% increase. The company also saw a substantial improvement in profitability, with a 44.38% increase in profit. The company's net worth Soared by an impressive increase of 36.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maiva Pharma?
In 2023, Maiva Pharma had a promoter holding of 13.76% and a public holding of 86.24%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Symbiotec Zenfold Private LimitedBuggana Hariharnath is a mutual person
- Symbiotec Pharmalab Private Limited
Buggana Hariharnath is a mutual person
Clearmedi Healthcare Private LimitedNirav Mehta is a mutual person
Aurigene Oncology LimitedBuggana Hariharnath is a mutual person
Invascent Advisory Services India LlpBuggana Hariharnath is a mutual person
Morgan Stanley Investment Management Private LimitedNirav Mehta is a mutual person
Charges (Loans)
₹268.00 Cr
₹4.10 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 268.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Oct 2020 | Hdfc Bank Limited | ₹124.00 Cr | Open |
| 20 Oct 2020 | Hdfc Bank Limited | ₹20.00 Cr | Open |
| 11 Sep 2020 | Hdfc Bank Limited | ₹124.00 Cr | Open |
| 25 Mar 2002 | Indian Bank | ₹1.60 Cr | Satisfied |
| 25 Mar 2002 | Indian Bank | ₹2.50 Cr | Satisfied |
How Many Employees Work at Maiva Pharma?
Maiva Pharma has a workforce of 751 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maiva Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maiva Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
